1. Home
  2. NLSP vs KAVL Comparison

NLSP vs KAVL Comparison

Compare NLSP & KAVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • KAVL
  • Stock Information
  • Founded
  • NLSP 2015
  • KAVL 1998
  • Country
  • NLSP Switzerland
  • KAVL United States
  • Employees
  • NLSP N/A
  • KAVL N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • KAVL Medicinal Chemicals and Botanical Products
  • Sector
  • NLSP Health Care
  • KAVL Health Care
  • Exchange
  • NLSP Nasdaq
  • KAVL Nasdaq
  • Market Cap
  • NLSP 6.9M
  • KAVL 7.9M
  • IPO Year
  • NLSP 2021
  • KAVL N/A
  • Fundamental
  • Price
  • NLSP $1.49
  • KAVL $0.56
  • Analyst Decision
  • NLSP
  • KAVL
  • Analyst Count
  • NLSP 0
  • KAVL 0
  • Target Price
  • NLSP N/A
  • KAVL N/A
  • AVG Volume (30 Days)
  • NLSP 31.2K
  • KAVL 93.7K
  • Earning Date
  • NLSP 05-14-2025
  • KAVL 04-15-2025
  • Dividend Yield
  • NLSP N/A
  • KAVL N/A
  • EPS Growth
  • NLSP N/A
  • KAVL N/A
  • EPS
  • NLSP N/A
  • KAVL N/A
  • Revenue
  • NLSP N/A
  • KAVL $3,877,695.00
  • Revenue This Year
  • NLSP N/A
  • KAVL N/A
  • Revenue Next Year
  • NLSP N/A
  • KAVL N/A
  • P/E Ratio
  • NLSP N/A
  • KAVL N/A
  • Revenue Growth
  • NLSP N/A
  • KAVL N/A
  • 52 Week Low
  • NLSP $1.30
  • KAVL $0.52
  • 52 Week High
  • NLSP $18.40
  • KAVL $9.69
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 42.38
  • KAVL 33.73
  • Support Level
  • NLSP $1.30
  • KAVL $0.52
  • Resistance Level
  • NLSP $1.60
  • KAVL $0.60
  • Average True Range (ATR)
  • NLSP 0.10
  • KAVL 0.05
  • MACD
  • NLSP 0.02
  • KAVL 0.02
  • Stochastic Oscillator
  • NLSP 54.29
  • KAVL 27.34

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About KAVL Kaival Brands Innovations Group Inc.

Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.

Share on Social Networks: